Last reviewed · How we verify
Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Xgeva® in Healthy Adults
A randomized, double-blind and parallel group study to compare the pharmacokinetic, safety and pharmacodynamic of QL1206 and Xgeva® in healthy adults.
Details
| Lead sponsor | Qilu Pharmaceutical Co., Ltd. |
|---|---|
| Phase | PHASE1 |
| Status | COMPLETED |
| Enrolment | 168 |
| Start date | Mon Aug 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Wed May 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Healthy People
Interventions
- QL1206
- Xgeva®
Countries
China